Skip to main content
NovaBay Pharmaceuticals, Inc. logo

NovaBay Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · NBY ISIN · US66987P2011 LEI · 549300D5U7PQPNEX8Q38 US Manufacturing
Open in API
Filings indexed 1,026 across all filing types
Latest filing 2024-06-28 Regulatory Filings
Country US United States of America
Listing US NBY

About NovaBay Pharmaceuticals, Inc.

https://novabay.com/

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2024
Regulatory Filings
2024-06-28 English
Regulatory Filings 2024
Regulatory Filings
2024-06-28 English
Regulatory Filings 2024
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of effectiveness for a Form S-1 registration statement under Rule 461 of the Securities Act of 1933. It is a correspondence related to a registration statement becoming effective, not the registration statement itself or a financial report. The document is short (918 characters) and serves as a formal request rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory communications that do not fit other specific categories.
2024-06-25 English
Regulatory Filings 2024
Regulatory Filings Classification · 90% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. There is no indication of the document being a report itself or an announcement of a report. Due to the lack of identifiable information and the fallback rule for documents that do not fit any specific category, the appropriate classification is Regulatory Filings (RNS). The document length is sufficient to exclude it being a mere announcement or certification, but the content is not interpretable for more specific classification.
2024-06-25 English
Regulatory Filings 2024
Regulatory Filings Classification · 95% confidence The provided document text appears to be heavily encoded or corrupted, containing no readable or meaningful financial, regulatory, or corporate information. There are no identifiable keywords, regulatory references, form names, fiscal periods, or document titles that would allow classification into any specific filing category. The text does not contain any clear financial statements, management commentary, announcements, or other typical content of financial filings. Given the lack of discernible content, the document cannot be classified as a substantive report or announcement. According to the fallback rule, such documents should be classified as Regulatory Filings (RNS). The confidence is high because the text is unreadable and does not fit any other category.
2024-06-25 English
FORM S-1
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for registering securities for public offering under the Securities Act of 1933. It includes detailed information about the securities being offered, underwriting, risk factors, and other disclosures typical of an initial or follow-on public offering registration statement. This is not an annual report, earnings release, or any other type of financial or governance report. It is a capital markets filing related to fundraising and securities issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains the full registration statement text, not just an announcement or notice, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2024-06-21 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.